Brooke Prinzing

Title: Brooke Prinzing: Innovator in Chimeric Antigen Receptors

Introduction

Brooke Prinzing is a notable inventor based in Memphis, TN (US). She has made significant contributions to the field of immunology through her innovative work on chimeric antigen receptors. Her research focuses on enhancing the effectiveness of these receptors in targeting specific cancer cells.

Latest Patents

Brooke Prinzing holds a patent for "Chimeric antigen receptors with MYD88 and CD40 costimulatory domains." This patent relates to a chimeric antigen receptor that targets Eph receptors, facilitating the activation of co-stimulatory pathways. The application also encompasses polynucleotides encoding the chimeric antigen receptor, vectors, and host cells that incorporate this receptor. Furthermore, it details methods for preparing host cells with the chimeric antigen receptor to improve their in vivo effector function. She has 1 patent to her name.

Career Highlights

Throughout her career, Brooke has worked with prestigious institutions such as St. Jude Children's Research Hospital and Baylor College of Medicine. Her work in these organizations has allowed her to contribute to groundbreaking research in the field of cancer treatment.

Collaborations

Brooke Prinzing has collaborated with esteemed colleagues, including Stephen Gottschalk and Giedre Krenciute. These partnerships have furthered her research and innovation in the development of chimeric antigen receptors.

Conclusion

Brooke Prinzing is a pioneering inventor whose work on chimeric antigen receptors is making a significant impact in the field of immunology. Her contributions are paving the way for advancements in cancer treatment and therapy.